tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TSE:DRUG Stock Latest News

Compelling Phase 2 Data and Prader–Willi Upside Support Buy Rating and Favorable Risk/Reward for DRUG
RatingsCompelling Phase 2 Data and Prader–Willi Upside Support Buy Rating and Favorable Risk/Reward for DRUG
8d ago
DRUG
De-Risked Neurology Pipeline and Pivotal 2026 Catalysts Underpin Buy Rating on BMB-101 Franchise
PremiumRatings
De-Risked Neurology Pipeline and Pivotal 2026 Catalysts Underpin Buy Rating on BMB-101 Franchise
11d ago
DRUG
Bright Minds price target lowered to $126 from $142 at Baird
PremiumThe Fly
Bright Minds price target lowered to $126 from $142 at Baird
11d ago
DRUG
Bright Minds Biosciences Files Q1 FY2026 Financials Showing Strong Cash, Higher R&D Loss
PremiumCompany Announcements
Bright Minds Biosciences Files Q1 FY2026 Financials Showing Strong Cash, Higher R&D Loss
12d ago
6K
DRUG
Bright Minds Biosciences Raises US$175 Million in Share Offering to Advance CNS Drug Pipeline
PremiumCompany Announcements
Bright Minds Biosciences Raises US$175 Million in Share Offering to Advance CNS Drug Pipeline
2M ago
6K
DRUG
Bright Minds Biosciences Launches $175 Million Share Offering to Fund Neurology Drug Pipeline
PremiumCompany AnnouncementsBright Minds Biosciences Launches $175 Million Share Offering to Fund Neurology Drug Pipeline
2M ago
6K
DRUG
Psychedelic: Bright Minds reports results from Phase 2 BMB-101 trial
Premium
The Fly
Psychedelic: Bright Minds reports results from Phase 2 BMB-101 trial
2M ago
CMPS
DRUG
Bright Minds 1.945M share Secondary priced at $90.00
Premium
The Fly
Bright Minds 1.945M share Secondary priced at $90.00
2M ago
DRUG
Bright Minds Biosciences Prices Upsized US$175 Million Public Offering and Ends ATM Program
PremiumCompany Announcements
Bright Minds Biosciences Prices Upsized US$175 Million Public Offering and Ends ATM Program
2M ago
6K
DRUG
Bright Minds Biosciences Ends Equity Distribution Deal With Piper Sandler and Cantor
PremiumCompany Announcements
Bright Minds Biosciences Ends Equity Distribution Deal With Piper Sandler and Cantor
2M ago
6K
DRUG
Bright Minds price target raised to $142 from $82 at Baird
PremiumThe Fly
Bright Minds price target raised to $142 from $82 at Baird
2M ago
DRUG
Bright Minds price target raised to $147 from $72 at BTIG
PremiumThe Fly
Bright Minds price target raised to $147 from $72 at BTIG
2M ago
DRUG
Bright Minds Biosciences Launches US$100 Million Public Offering to Fund CNS Drug Pipeline
PremiumCompany AnnouncementsBright Minds Biosciences Launches US$100 Million Public Offering to Fund CNS Drug Pipeline
2M ago
6K
DRUG
Bright Minds Biosciences: Encouraging BMB-101 Efficacy, Pipeline Expansion, and Valuation Upside Support Maintained Buy Rating
Premium
Ratings
Bright Minds Biosciences: Encouraging BMB-101 Efficacy, Pipeline Expansion, and Valuation Upside Support Maintained Buy Rating
2M ago
DRUG
Bright Minds Biosciences Unveils Strong Phase 2 Data for BMB-101 in Drug-Resistant Seizure Disorders
Premium
Company Announcements
Bright Minds Biosciences Unveils Strong Phase 2 Data for BMB-101 in Drug-Resistant Seizure Disorders
2M ago
6K
DRUG
Bright Minds announces $100M common shares offering
PremiumThe Fly
Bright Minds announces $100M common shares offering
2M ago
DRUG
Bright Minds Biosciences: Robust BMB-101 Phase 2 Data and Clear Registrational Path Underpin $115 Target and Buy Rating
PremiumRatings
Bright Minds Biosciences: Robust BMB-101 Phase 2 Data and Clear Registrational Path Underpin $115 Target and Buy Rating
2M ago
DRUG
Bright Minds announces results from Phase 2 BREAKTHROUGH trial of BMB-101
PremiumThe Fly
Bright Minds announces results from Phase 2 BREAKTHROUGH trial of BMB-101
2M ago
DRUG
Bright Minds Biosciences Sets January 6 Webcast for BMB-101 Phase 2 Topline Results in Drug-Resistant Absence Seizures
PremiumCompany Announcements
Bright Minds Biosciences Sets January 6 Webcast for BMB-101 Phase 2 Topline Results in Drug-Resistant Absence Seizures
2M ago
6K
DRUG
Bright Minds Biosciences: Buy Rating Reiterated on BMB-101’s Potential Best-in-Class Profile and Multi-Billion-Dollar Peak Sales Opportunity
PremiumRatingsBright Minds Biosciences: Buy Rating Reiterated on BMB-101’s Potential Best-in-Class Profile and Multi-Billion-Dollar Peak Sales Opportunity
2M ago
DRUG
Is DRUG a Buy, Before Earnings?
Premium
Pre-Earnings
Is DRUG a Buy, Before Earnings?
2M ago
DRUG
Bright Minds Biosciences Strengthens Advisory Board with PWS Experts
Premium
Company Announcements
Bright Minds Biosciences Strengthens Advisory Board with PWS Experts
3M ago
DRUG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >